Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Oncotarget ; 7(46): 74602-74611, 2016 Nov 15.
Article in English | MEDLINE | ID: mdl-27806341

ABSTRACT

Major histocompatibility complex (MHC) class I molecules present antigenic peptides to cytotoxic T cells. During an adaptive immune response, MHC molecules are regulated by several mechanisms including lipopolysaccharide (LPS) and interferon gamma (IFN-g). However, it is unclear whether the serine protease cathepsin G (CatG), which is generally secreted by neutrophils at the site of inflammation, might regulate MHC I molecules. We identified CatG, and to a higher extend CatG and lactoferrin (LF), as an exogenous regulator of cell surface MHC I expression of immune cells and glioblastoma stem cells. In addition, levels of MHC I molecules are reduced on dendritic cells from CatG deficient mice compared to their wild type counterparts. Furthermore, cell surface CatG on immune cells, including T cells, B cells, and NK cells triggers MHC I on THP-1 monocytes suggesting a novel mechanism for CatG to facilitate intercellular communication between infiltrating cells and the respective target cell. Subsequently, our findings highlight the pivotal role of CatG as a checkpoint protease which might force target cells to display their intracellular MHC I:antigen repertoire.


Subject(s)
Cathepsin G/pharmacology , Glioblastoma/genetics , Glioblastoma/metabolism , Histocompatibility Antigens Class I/metabolism , Immune System/cytology , Immune System/metabolism , Animals , Cathepsin G/genetics , Cathepsin G/metabolism , Cell Line , Cell Line, Tumor , Cell Membrane/metabolism , Disease Models, Animal , Female , Gene Expression Regulation, Neoplastic/drug effects , Glioblastoma/immunology , Histocompatibility Antigens Class I/genetics , Humans , Immune System/immunology , Lactoferrin/metabolism , Male , Mice , Mice, Knockout , Monocytes/drug effects , Monocytes/metabolism , Neoplastic Stem Cells/drug effects , Neoplastic Stem Cells/metabolism , Proteolysis
SELECTION OF CITATIONS
SEARCH DETAIL
...